3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Nasopharyngeal Carcinoma
20
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Prostatic Neoplasms
5
Carcinoma
4
Rectal Neoplasms
3
Nasopharyngeal Neoplasms
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Pancreatic Adenocarcinoma
2
Neoplasm Metastasis
2
Meningeal Carcinomatosis
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tumor Virus Infections
1
Thyroid Carcinoma, Anaplastic
1
Stomatognathic Diseases
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Sarcoma
1
Recurrence
1
Interventions
tempol
1
maltodextrin
1
Xylitol
1
Radiotherapy, Intensity-Modulated
1
RRx-001
1
Injections
1
Folic Acid
1
Cisplatin
1
Betaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Mucositis
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT05966194
2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2
Recruiting
216 enrolled